• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Healthcare reform in china
 

Healthcare reform in china

on

  • 879 views

 

Statistics

Views

Total Views
879
Views on SlideShare
879
Embed Views
0

Actions

Likes
0
Downloads
7
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Healthcare reform in china Healthcare reform in china Document Transcript

    • Healthcare reform in ChinaPublished:October 2011No.Of Pages:112Price:US $ 3835IntroductionThis report gives an overview of China’s demographics, overall healthcare infrastructure,and the need for healthcare reforms. It provides detailed coverage of China healthcarereform plans from the viewpoint of pharmaceutical companies, payers, and healthcareproviders. Reforms and implications for various stakeholders are assessed and commentsfrom 23 managers at Chinese hospitals included.Features and benefits* Learn how healthcare is being reformed in China and the effects on various industrystakeholders.* Develop strategies for successful market penetration in China.* Understand the regulatory structures which affect how drugs are approved andreimbursed in China.* Gain insights about the effects of reform from a Scrip Business Insights survey of 23managers at Chinese hospitals.* Evaluate the importance of tier 2 and 3 cities in Chinas pharmaceutical market.Highlights* Historically, China had a very high out-of-pocket expenditure on healthcare. However, theproportion of out-of-pocket expenditure on healthcare dropped from 60% in 2001 to 40% in2008 due to the increasing coverage of social health insurance schemes.* China’s population will increase by 85m people between 2010 and 2020. 85% of this willbe accounted for by an increase in the population of over 60s, which will prompt growth inmarkets for cardiovascular diseases, dementia, and other age-linked conditions. A sharp risein lifestyle diseases such as diabetes and obesity is also underway.* Reforms are set to present opportunities for pharma companies, CROs, medical devicemanufacturers, and private health insurance providers. Healthcare IT is also set for a boost,as the government begins to invest in electronic health records.Browse All Healthcare Market Research ReportsTable Of ContentsAbout the authorDisclaimerEXECUTIVE SUMMARYChina’s changing population
    • China’s healthcare system and the need for reformHealthcare reform in ChinaImplications of reforms for stakeholdersChina’s changing populationSummaryIntroductionIncreasing populationAging populationChange in therapeutic focusThe rise of the middle class and increase in spending powerUrbanizationCity expansion in ChinaMaximizing the opportunity of smaller city marketsChina’s healthcare system and the need for reformSummaryOverviewHistory of Chinese healthcareRegulatory structure and government departmentsThe Ministry of HealthThe State Food and Drug AdministrationMinistry of Human Resources and Social SecurityNational Development and Reform CommissionOther healthcare related agenciesNew drug regulation lawsNew drug registration proceduresDrug recallsOrganization of healthcare and the hospital systemUrban healthcareRural healthcareDifferences in hospital healthcareUrban healthcare and rural healthcarePricing and reimbursement in ChinaApproving drugs for reimbursementTraditional Chinese MedicineHealthcare reform in ChinaSummaryUniversal medical insuranceBasic Medical InsuranceUrban Resident Basic Medical InsuranceNew Rural Cooperative Medical InsurancePrivate insuranceAssessment of health insurance programsDrug pricing reformEssential Drug ListThe National Reimbursement Drug ListHospital reformIncreasing the number of community health clinicsReform of hospital financeImplications of reforms for stakeholders
    • SummaryIntroductionPharmaceutical companiesHospitalsSelected responses to three qualitative survey questionsPrivate hospital opportunitiesContact research organizationsMedical device companiesPrivate health insurance companiesHealthcare IT companiesAssessment and conclusionAppendixScopeMethodologyGlossary/AbbreviationsReferencesCompany press releasesInforma productsQuestionnaire responsesResearch procedureDetailed questionnaire responsesLIST OF TABLESTable: China’s population composition and projections by age groupTable: China’s urban and rural population (m), 2000–50Table: Composition of the expenditure for public health in China, 2001–08Table: Evolution of social medical insurance in ChinaTable: Overview of China’s healthcare related agenciesTable: Urban and rural levels of healthcareTable: Statistics on New Rural Cooperative Medical System, 2004–09Table: Financing Structure of NRCMS in Xiangtan City (RMB), 2005–09Table: Overview of government subsidised medical insurance programsTable: Comparison of the top 10 international additions/removals of key drugs, 2004–09Table: Utilization rate for community health centres, 2002–09Table: Number of privately owned medical institutions in China, 2008Table: Six hospital categories covered for the questionnaireLIST OF FIGURESFigure: China’s population growth rate, 1990–2010Figure: China’s population, 1990–2030Figure: Diabetes prevalence in China, India, US, UK, and Japan, 2010Figure: Average wage of employed persons in urban units in China, 1995–2009Figure: China’s middle class population increase, 2010–15Figure: China’s urban and rural population (m), 2000–50Figure: Comparison of healthcare expenditure in the US and ChinaFigure: Composition of the expenditure for Public Health in China (2001–08)Figure: Lists A and B on the NRDL
    • Figure: Repositioning of medical institutionsFigure: Decision criteria for pharmaceutical companies to seek listing on NRDLFigure: Application and approval procedure for clinical trialsFigure: Private health insurance market opportunity in China ($bn), 2008–20About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog